(Q41429380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Novel approaches to the prevention and therapy of neonatal bacterial sepsis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

E M Perez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

L E Weisman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Clinics in Perinatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

213-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Exchange blood transfusion and on-line plasma exchange for sepsis in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Granulocyte colony stimulating factor treatment for neonatal neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Tumor necrosis factor in the pathogenesis of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Effect of scavengers of oxygen-derived free radicals on mortality in endotoxin-challenged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Prophylactic or Simultaneous Administration of Recombinant Human Granulocyte Colony Stimulating Factor in the Treatment of Group B Streptococcal Sepsis in Neonatal Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Diphosphoryl lipid A from Rhodopseudomonas sphaeroides induces tolerance to endotoxic shock in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Exchange transfusion as an alternative to granulocyte concentrate administration in neonates with bacterial sepsis and profound neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Strategies for blocking the systemic effects of cytokines in the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Intravenous immune globulin: a cautionary note

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Diagnostic value of plasma levels of tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) in newborns with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Monoclonal antibody to TNF in severe septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Group B streptococcus induces tumor necrosis factor in neonatal piglets. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Serum tumour necrosis factor in newborns at risk for infections

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

The effects of aminophylline and pentoxifylline on multiple organ damage after Escherichia coli sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Molecular basis for group B beta-hemolytic streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Comparative protective activity of human monoclonal and hyperimmune polyclonal antibody against group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

High-dose intravenous immune globulin impairs antibacterial activity of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Biology and therapeutic uses of myeloid hematopoietic growth factors and interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

L-arginine pathway in the sepsis syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Adjunctive therapy for septic shock: a review of experimental approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Exchange transfusion in neutropenic septicemic neonates: effect on granulocyte functions

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Heparin in experimental hyperdynamic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Plasma exchange therapy for endotoxin shock in puppies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Using Granulocyte Colony-Stimulating Factor for Neutropenia During Neonatal Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Granulocyte colony-stimulating factor for neutropenia in neonatal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

A comparative study on the value of exchange and blood transfusion in the management of severe neonatal septicemia with sclerema

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Topical ointment therapy benefits premature infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Pathogenetic mechanisms of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Exchange transfusion in newborn infants: effects on granulocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Effects of a nitric oxide synthase inhibitor in humans with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Blood filtration in children with severe sepsis: safe adjunctive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Thromboxane receptor blockade (SQ 29,548) in group B streptococcal toxin challenge in young lambs.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Continuous arteriovenous hemofiltration (CAVH) in a premature newborn as treatment of overhydration and hyperkalemia due to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Plasma nitric oxide levels in newborn infants with sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Granulocyte and granulocyte-macrophage colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Immunoglobulin secretion by the normal and the infected newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Endotoxin clearance by exchange blood transfusion in septic shock neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Treatment of septicaemia in the newborn infant: choice of initial antimicrobial drugs and the role of exchange transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Recombinant haemopoietic growth factors in the newborn — will they be useful?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Anti-endotoxin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Standard versus hyperimmune intravenous immunoglobulin in preventing or treating neonatal bacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Opsonic activity of commercially available standard intravenous immunoglobulin preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Treatment of sepsis and septic shock: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Therapeutic use of recombinant human granulocyte-macrophage colony-stimulating factor in neonatal rats with type III group B streptococcal sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

The role of hematopoietic growth factors in transfusion medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Immunologic basis for increased susceptibility of the neonate to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

Arteriovenous hemofiltration in children with multiple organ system failure

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930193-3

7 January 2021

10.1016/S0095-5108(18)30193-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099511%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference